- Last edited on February 9, 2022
Differences
This shows you the differences between two versions of the page.
|
geri:dementia:parkinsons [on March 16, 2019] |
geri:dementia:parkinsons [on April 17, 2019] |
||
|---|---|---|---|
| Line 45: | Line 45: | ||
| * Major or mild [[geri:dementia:vascular|vascular neurocognitive disorder]] | * Major or mild [[geri:dementia:vascular|vascular neurocognitive disorder]] | ||
| * Neurocognitive disorder due to another medical condition (e.g., neurodegenerative disorders) | * Neurocognitive disorder due to another medical condition (e.g., neurodegenerative disorders) | ||
| - | * Neuroleptic-induced [[meds:side-effects:eps|parkinsonism]] | + | * Neuroleptic-induced [[meds:antipsychotics:eps|parkinsonism]] |
| * Other medical conditions and [[cl:1-delirium|delirium]]. Delirium and neurocognitive impairments due to side effects of dopamine-blocking drugs and other medical conditions (e.g., sedation or impaired cognition, severe hypothy roidism, Bi2deficiency) must also be ruled out. Sometimes it may be clinically difficult to distinguish between Parkinsons's dementia and delirium, and patients must be followed longitudinally. | * Other medical conditions and [[cl:1-delirium|delirium]]. Delirium and neurocognitive impairments due to side effects of dopamine-blocking drugs and other medical conditions (e.g., sedation or impaired cognition, severe hypothy roidism, Bi2deficiency) must also be ruled out. Sometimes it may be clinically difficult to distinguish between Parkinsons's dementia and delirium, and patients must be followed longitudinally. | ||